Journals / Türk Patoloji Dergisi / 2008 / Cilt: 24 - Sayı: 1

Acral myxoinflammatory fibrablastic sarcoma: Report of six cases

Akral miksoinflamatuar fibroblastik sarkom: Altı olgu sunumu

Pages
44–49
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In one of our cases, recurrence was observed; in none of our cases metastasis has been determined.It included many tumoral and non-tumoral lesions in differential diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acral myxoinflammatory fibroblastic sarcoma was first described in 1998.
📊
Key Findings & Data:The age range is broad (mean age 40).
💡
Conclusion & Impact:In one of our cases, recurrence was observed; in none of our cases metastasis has been determined.It included many tumoral and non-tumoral lesions in differential diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acral myxoinflammatory fibroblastic sarcoma was first described in 1998. The tumor typically involves distal extremities; especially fingers and toes. It is usually located in subcutaneous tissue. The age range is broad (mean age 40). The size of tumor varies between 1-8 cm. Microscopically, myxoid and hyaline zones are characteristic. Inflammatory cells are abundant and there are large cells resembling Reed-Sternberg or ganglion cells and multivacuolated cells having lipoblast-like appearance.We present 6 cases of acral myxoinflammatory fibroblastic sarcoma, locations were ankle, 1st toe and hand. The most presenting symptoms were swelling with or without pain and they have lasted for 3,5 months-4 years.Immunohistochemical studies of our cases, revealed vimentin (5/5), CD68 (5/5), CD34 (1/3) positivity. Ki-67 proliferation indices varied between 2-10%. Five patients underwent tumor excision, while in one patient amputation had been performed.This tumor is a low grade sarcoma but has the potential of recurrence and even metastasis, though it is rare. In one of our cases, recurrence was observed; in none of our cases metastasis has been determined.It included many tumoral and non-tumoral lesions in differential diagnosis.

Özet

Akral miksoinflamatuar sarkom, ilk kez 1998 yılında tanımlanmıştır. Tümör özellikle el ve ayak parmakları olmak üzere, distal ekstremiteleri tutar. Genellikle subkutan dokuda lokalizedir. Görüldüğü yaş aralığı geniştir (ortalama yaş 40). Tümör çapı 1-8 cm arasında değişir. Mikroskopik olarak, miksoid ve hiyalin alanlarla karakterize olup bol inflamatuar hücre, Reed-Sternberg ya da ganglion hücrelerine benzer büyük hücreler ve multivakuollü lipoblast benzeri hücreler görülür.Altı olgumuzda lezyonun yerleşim yerleri ayak bileği, ayak 1. parmak ve eldir. En çok gözlenen bulgu, 3,5 ay- 4 yıllık semptom süresi içinde, ağrılı ya da ağrısız şişliktir.İmmünhistokimyasal çalışmalarda; vimentin (5/5), CD68 (5/5), CD34 (1/3) pozitif bulunmuştur. Ki-67 proliferasyon indeksi %2-10 arasında değişmektedir. Beş hastaya tümör eksizyonu, bir hastaya amputasyon uygulanmıştır.Bu tümör düşük-dereceli bir sarkomdur fakat nadir olarak rekürrens ve hatta metastaz yapabilir. Bir olgumuzda rekürrens gözlenmiş olup, olguların hiçbirisinde metastaz saptanmamıştır.Ayırıcı tanıda birçok tümöral ve nontümöral lezyon bulunmaktadır.

🔖

Cite This Article

UZUNER, E. G., DEMİRYONT, M., BİLGİÇ, B., ÖZGER, H. (2022). Acral myxoinflammatory fibrablastic sarcoma: Report of six cases. Türk Patoloji Dergisi, Cilt: 24 - Sayı: 1, 44–49. https://ajindex.com/articles/640872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Meis-Kindblom JM, Kindblom L. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet. Am J Surg Pathol 1998;22:911-924
  2. Montgomery EA, Devaney KO, Giordano TJ, Weiss SW. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Mod Pathol 1998;11:384-391
  3. Michal M. Inflammatory myxoid tumor of the soft parts with bizarre giant cells. Pathol Res Pract 1998; 194:529-533
  4. Miettinen M. Malignant and Potentially Malignant Fibroblastic and Myofibroblastic Tumors. In Diagnostic Soft Tissue Pathology 1st ed. Churchill Livingstone Philadelphia, 2003;196
  5. Kindblom LG, Meis-Kindblom JM. Myxoinflammatory fibroblastic sarcoma. In WHO Classification of Tumors Pathology and Genetics/Tumors of Soft Tissue and Bone. Eds. Fletcher CDM, Unni KK, Mertens F., IARC Press Lyon. 2002;96-97
  6. Lambert I, Debiec-Rychter M, Guelinckx P, Hagemeijer A, Sciot R. Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes. Virchows Arch 2001;438:509-512
  7. Sakaki M, Hirokawa M, Wakatsuke S. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature. Virchows Arch 2003; 442:25-30
  8. Weiss SW, Goldblum JR. Soft Tissue Tumors of Intermediate Malignancy of Uncertain Type. In: Enzinger and Weiss's Soft Tissue Tumors 5th.ed Mosby St. Louis. London. 2008;1101-1108
  9. Lang JE, Dodd L, Martinez S, Brigman BE. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review. Clin Orthop Relat Res 2006;445:254-260.